Literature DB >> 10468193

Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo.

T Caixia1, F Hongwen, L Xiran.   

Abstract

In order to study the possible role of soluble interleukin-2 receptor (sIL-2R) in the pathogenesis of vitiligo, we measured the levels of sIL-2R in the sera and the tissue fluids from skin lesions and uninvolved skin from 41 patients with vitiligo, using the method of sandwich ELISA with monoclonal and polyclonal antibodies. The results showed that the overall level of serum sIL-2R from patients with vitiligo was significantly higher than that from normal control group (P<0.01). The serum level of sIL-2R in both generalized and focal types was significantly higher than that in normal control group (P<0.01), but there was no significant difference between the segmental type and normal control group (P>0.05). The level of serum sIL-2R from patients with vitiligo in progressive stage was significantly higher than that in stable stage (P<0.01). The level of sIL-2R in the tissue fluid from the skin lesion of the patient was significantly higher than uninvolved skin of the same patient (P<0.05). The above data indicate that there is an association between the expression of sIL-2R and the pathogenesis of vitiligo. The level of serum sIL-2R in vitiligo is related to the activity of the disease, therefore the measurement of it may be significant in estimating the severity and the prognosis of the disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468193     DOI: 10.1016/s0923-1811(99)00029-8

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  7 in total

Review 1.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

Review 2.  New treatment modalities for vitiligo: focus on topical immunomodulators.

Authors:  Kresimir Kostovic; Aida Pasic
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity.

Authors:  James P Strassner; Mehdi Rashighi; Maggi Ahmed Refat; Jillian M Richmond; John E Harris
Journal:  J Am Acad Dermatol       Date:  2017-03-01       Impact factor: 11.527

Review 4.  Translational Research in Vitiligo.

Authors:  Erica L Katz; John E Harris
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

5.  Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients.

Authors:  E Reimann; K Kingo; M Karelson; P Reemann; E Vasar; H Silm; S Kõks
Journal:  Dermatopathology (Basel)       Date:  2014-01-09

6.  Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.

Authors:  Linrong He; Xiaoming Shu; Xia Liu; Yongpeng Ge; Sizhao Li; Xin Lu; Guochun Wang
Journal:  Mediators Inflamm       Date:  2020-07-28       Impact factor: 4.711

7.  Urinary metabolomic investigations in vitiligo patients.

Authors:  Wei Liu; Xiao-Yan Liu; Yue-Tong Qian; Dong-Dong Zhou; Jia-Wei Liu; Tian Chen; Wei Sun; Dong-Lai Ma
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.